First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors
Clinical trial NCT04622774 · COMPLETED
Trial details
- NCT number
- NCT04622774
- Sponsor
- ImmunoGen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-29
- Primary completion
- 2023-12-28
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.